Purigen Biosystems, Inc.

Nucleic Acid Purification – Pure and Simple

About Purigen Biosystems

Purigen Biosystems' transformative Ionic Purification System provides a hands-free solution for extracting, enriching and quantifying DNA and RNA from biological samples. Our proprietary approach uses isotachophoresis (ITP), an electric-field-driven technique for purifying, focusing, and/or separating species. The application of ITP to purify and quantify nucleic acids from complex biological samples was pioneered by Purigen co-founder, Stanford Professor Juan G. Santiago. The Ionic® Purification System is compatible with a range of samples including cells and FFPE.

Purigen is proudly affliated with StartX Med, a Stanford-University-affliated nonprofit technology accelerator, and the California Life Sciences Institute’s (CLSI) FAST Advisory Program.

SmartX Med and Purigen Biosystems California Life Sciences Institute and Purigen Biosystems

Leadership Team

  • Barney E. Saunders, Ph.D.
     | CEO
  • Klint Rose, Ph.D.
     | CSO and Co-founder
  • Steve Reichenbach
     | CFO
  • Pam Delucchi
     | SVP of Operations
  • Chris Grimley
     | SVP of Sales and Marketing

Board of Directors

  • Joseph J. Victor
    Executive Chairman of the Board of Directors
  • Mira Chaurushiya, Ph.D.
    Principal – 5AM Ventures
  • Bill W. Colston, Ph.D.
    CEO of Sestina Bio
  • Barney E. Saunders, Ph.D.
    CEO of Purigen Biosystems
  • Mitchell Mutz, Ph.D.
    Investment Director – Roche Venture Fund
  • Kevin Corcoran
    Vice President and General Manager - Agilent

Scientific Advisory Board

  • Juan Santiago, Ph.D.
    Scientific Advisor and Co-founder
  • Doug Amorese
    CSO, Nugen

  • Sean Bendall, Ph.D.
    Assistant Professor of Pathology, Stanford University